Clinical Trial Update: Increasing Resiliency Among Early Post-Treatment Lymphoma Survivors [NA]

View source ↗

Summary

Massachusetts General Hospital is conducting a clinical trial to increase resiliency among lymphoma survivors who have recently completed treatment. The study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Lymphoma | NA | Status: NOT_YET_RECRUITING